NCT04766879View on ClinicalTrials.gov

Spatial Repellents for the Prevention of Malaria in Kenya

NACompletedINTERVENTIONAL
Enrollment

5,984

Participants

Timeline

Start Date

March 2, 2021

Primary Completion Date

October 23, 2023

Study Completion Date

December 9, 2023

Conditions
Malaria
Interventions
DEVICE

Transfluthrin

Passive emanator with formulated transfluthrin

DEVICE

Placebo

Passive emanator with formulated inert ingredients

Trial Locations (2)

Unknown

Centers for Disease Control and Prevention, Busia

Kenya Medical Research Institute (KEMRI), Busia

Sponsors
All Listed Sponsors
collaborator

S.C. Johnson & Son, Inc.

INDUSTRY

collaborator

Kenya Medical Research Institute

OTHER

collaborator

Centers for Disease Control and Prevention

FED

collaborator

fhiClinical

UNKNOWN

lead

University of Notre Dame

OTHER